HBM Partners
Zug, Zughbmpartners.com
Overview
HBM Partners is a globally active, Swiss-based, healthcare-focused investment advisor with over USD 2.1 billion in assets under management. The firm focuses on venture, growth and buy-out financings of private companies as well as investments in public companies in the biopharma, medtech, diagnostics and healthcare sectors in Europe and North America as well as in India, China and other Emerging Markets. HBM Partners advises SIX-listed HBM Healthcare Investments Ltd and several specialised public and private equity investment funds.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Curevo Vaccine | Mar 2025 | Series B | - |
| Shape Memory Medical | Mar 2024 | Series C | Co-investor |
| Shape Memory Medical | Mar 2024 | Series C | - |
| Neuron23 | Mar 2022 | Series C | - |
| Perfuze | Feb 2022 | Series A | Co-investor |
Key People
Chandra P. Leo
Partner
Priyanka Belawat
Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
